Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PI3K
Pharma
ASCO: Roche touts Itovebi's survival win in breast cancer showdown
Itovebi, when added to Pfizer’s Ibrance and AstraZeneca’s Faslodex, cut the risk of death by 33% in certain HR+/HER2- breast cancer patients.
Zoey Becker
May 22, 2025 5:00pm
Roche's Itovebi pads its case with overall survival win
Jan 28, 2025 4:00pm
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
Oct 10, 2024 5:30pm
Bayer, Novo separately opt to discontinue their Aliqopa, Levemir
Nov 9, 2023 9:10am
Takeda, Kyowa Kirin, Biogen—Fierce Pharma Asia
Oct 6, 2023 8:35am
'The Top Line': Alzheimer's developments, plus this week's headlines
Dec 9, 2022 6:00am
